{
  "id": "5173bdb38ed59a060a000020",
  "type": "factoid",
  "question": "How many TAp73 isoforms have been identified in humans?",
  "ideal_answer": "The TP73 gene, due to the presence of two promoters (P1 and P2) in its 5' flanking region, encodes a fully transcriptionally active domain (TAp73) and the amino terminus deleted (\u0394Np73). TAp73 possesses pro-apoptotic properties, while deltaNp73 has anti-apoptotic functions. Alternative 3'-end splicing results in generation of at least seven TAp73 distinctive isoforms ( \u03b1, \u03b2, \u03b3, etc ).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21946516",
    "http://www.ncbi.nlm.nih.gov/pubmed/22457351",
    "http://www.ncbi.nlm.nih.gov/pubmed/19139399",
    "http://www.ncbi.nlm.nih.gov/pubmed/16773194",
    "http://www.ncbi.nlm.nih.gov/pubmed/23271007",
    "http://www.ncbi.nlm.nih.gov/pubmed/21807636",
    "http://www.ncbi.nlm.nih.gov/pubmed/19885566",
    "http://www.ncbi.nlm.nih.gov/pubmed/20615966",
    "http://www.ncbi.nlm.nih.gov/pubmed/20926182",
    "http://www.ncbi.nlm.nih.gov/pubmed/22388545",
    "http://www.ncbi.nlm.nih.gov/pubmed/16254107",
    "http://www.ncbi.nlm.nih.gov/pubmed/18342333",
    "http://www.ncbi.nlm.nih.gov/pubmed/15059898",
    "http://www.ncbi.nlm.nih.gov/pubmed/12235210",
    "http://www.ncbi.nlm.nih.gov/pubmed/20298673",
    "http://www.ncbi.nlm.nih.gov/pubmed/21643019",
    "http://www.ncbi.nlm.nih.gov/pubmed/23470527",
    "http://www.ncbi.nlm.nih.gov/pubmed/11753569",
    "http://www.ncbi.nlm.nih.gov/pubmed/15610529",
    "http://www.ncbi.nlm.nih.gov/pubmed/14634023",
    "http://www.ncbi.nlm.nih.gov/pubmed/19861456",
    "http://www.ncbi.nlm.nih.gov/pubmed/12897129",
    "http://www.ncbi.nlm.nih.gov/pubmed/15975558",
    "http://www.ncbi.nlm.nih.gov/pubmed/12920125",
    "http://www.ncbi.nlm.nih.gov/pubmed/14676279",
    "http://www.ncbi.nlm.nih.gov/pubmed/15781249",
    "http://www.ncbi.nlm.nih.gov/pubmed/21852228",
    "http://www.ncbi.nlm.nih.gov/pubmed/16467208",
    "http://www.ncbi.nlm.nih.gov/pubmed/16322298",
    "http://www.ncbi.nlm.nih.gov/pubmed/19777343",
    "http://www.ncbi.nlm.nih.gov/pubmed/18546269",
    "http://www.ncbi.nlm.nih.gov/pubmed/15138575",
    "http://www.ncbi.nlm.nih.gov/pubmed/11830511",
    "http://www.ncbi.nlm.nih.gov/pubmed/12944917",
    "http://www.ncbi.nlm.nih.gov/pubmed/18350258",
    "http://www.ncbi.nlm.nih.gov/pubmed/15803372",
    "http://www.ncbi.nlm.nih.gov/pubmed/17626635",
    "http://www.ncbi.nlm.nih.gov/pubmed/22056305",
    "http://www.ncbi.nlm.nih.gov/pubmed/20146801",
    "http://www.ncbi.nlm.nih.gov/pubmed/19148480",
    "http://www.ncbi.nlm.nih.gov/pubmed/18477895",
    "http://www.ncbi.nlm.nih.gov/pubmed/19509292",
    "http://www.ncbi.nlm.nih.gov/pubmed/20733477",
    "http://www.ncbi.nlm.nih.gov/pubmed/20803057",
    "http://www.ncbi.nlm.nih.gov/pubmed/16964385",
    "http://www.ncbi.nlm.nih.gov/pubmed/20842728",
    "http://www.ncbi.nlm.nih.gov/pubmed/20581467",
    "http://www.ncbi.nlm.nih.gov/pubmed/19615968",
    "http://www.ncbi.nlm.nih.gov/pubmed/23159862",
    "http://www.ncbi.nlm.nih.gov/pubmed/16083956",
    "http://www.ncbi.nlm.nih.gov/pubmed/17076661",
    "http://www.ncbi.nlm.nih.gov/pubmed/19671150",
    "http://www.ncbi.nlm.nih.gov/pubmed/18039564",
    "http://www.ncbi.nlm.nih.gov/pubmed/18611950",
    "http://www.ncbi.nlm.nih.gov/pubmed/18469517",
    "http://www.ncbi.nlm.nih.gov/pubmed/16380414",
    "http://www.ncbi.nlm.nih.gov/pubmed/17029218",
    "http://www.ncbi.nlm.nih.gov/pubmed/17047653",
    "http://www.ncbi.nlm.nih.gov/pubmed/15889017",
    "http://www.ncbi.nlm.nih.gov/pubmed/22508983",
    "http://www.ncbi.nlm.nih.gov/pubmed/22484480",
    "http://www.ncbi.nlm.nih.gov/pubmed/20528922",
    "http://www.ncbi.nlm.nih.gov/pubmed/20194434",
    "http://www.ncbi.nlm.nih.gov/pubmed/23414597",
    "http://www.ncbi.nlm.nih.gov/pubmed/20807817",
    "http://www.ncbi.nlm.nih.gov/pubmed/11859407",
    "http://www.ncbi.nlm.nih.gov/pubmed/18256531",
    "http://www.ncbi.nlm.nih.gov/pubmed/23436675",
    "http://www.ncbi.nlm.nih.gov/pubmed/23362263",
    "http://www.ncbi.nlm.nih.gov/pubmed/23188674",
    "http://www.ncbi.nlm.nih.gov/pubmed/18583365",
    "http://www.ncbi.nlm.nih.gov/pubmed/21459846",
    "http://www.ncbi.nlm.nih.gov/pubmed/15752257",
    "http://www.ncbi.nlm.nih.gov/pubmed/16630058",
    "http://www.ncbi.nlm.nih.gov/pubmed/17430565",
    "http://www.ncbi.nlm.nih.gov/pubmed/18421303",
    "http://www.ncbi.nlm.nih.gov/pubmed/22740507",
    "http://www.ncbi.nlm.nih.gov/pubmed/17446929",
    "http://www.ncbi.nlm.nih.gov/pubmed/17912537",
    "http://www.ncbi.nlm.nih.gov/pubmed/15741235",
    "http://www.ncbi.nlm.nih.gov/pubmed/15467455",
    "http://www.ncbi.nlm.nih.gov/pubmed/16290057",
    "http://www.ncbi.nlm.nih.gov/pubmed/19103865",
    "http://www.ncbi.nlm.nih.gov/pubmed/19363520",
    "http://www.ncbi.nlm.nih.gov/pubmed/16980297",
    "http://www.ncbi.nlm.nih.gov/pubmed/17637683",
    "http://www.ncbi.nlm.nih.gov/pubmed/20613985"
  ],
  "snippets": [
    {
      "text": "A member of the p53 family, p73, has several isoforms and differentially regulates transcription of genes involved in the control of the cell cycle and apoptosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18256531",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and \u0394N isoforms. TAp73 has similar activity as p53 and functions as a tumor suppressor whereas \u0394Np73 has both pro- and anti-survival functions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21852228",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20615966",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We have evaluated the differential expression and subcellular localization of the functionally distinct apoptotic (TA) and anti-apoptotic (DeltaN) isoforms of p73 in non-small cell lung cancer (NSCLC), their possible association with p53 expression and determined the methylation status of the two p73 gene promoters (P1 and P2) in this tumor type.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19148480",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The role of various p73 isoforms in tumorigenesis has been controversial. However, as we have recently shown, the generation of TAp73-deficient (TAp73(-/-)) mice reveals that TAp73 isoforms exert tumor-suppressive functions, indicating an emerging role for Trp-73 in the maintenance of genomic stability. Unlike mice lacking all p73 isoforms, TAp73(-/-) mice show a high incidence of spontaneous tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19139399",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (deltaN) p73 isoforms. TAp73 possesses pro-apoptotic functions, while deltaNp73 has anti-apoptotic properties via functional inhibition of TAp73 and p53.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16980297",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The p73 gene is able to encode transcriptionaly active TAp73, as well as a dominant-negatively acting DeltaNp73 transcript isoforms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15138575",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Since some mutant p53 proteins and \u0394Np73 isoforms form heterocomplexes with TAp73, we asked whether p53 isoforms can do the same and potentially act as dominant-negative inhibitors of TAp73.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23188674",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "p73, a p53 family tumor suppressor, is expressed as TA and \u0394N isoforms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22508983",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "p73 is expressed as TA and \u0394N isoforms, both of which are implicated in tumor suppression and/or promotion.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22457351",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We found that TAp73 isoforms are down regulated in oocytes from women older than 38 years.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21946516",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic \u0394\u039dp73 isoforms respectively.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20926182",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "BRCA1-deficient ovarian carcinoma cells exhibit hypermethylation within a p73 regulatory region, which includes the binding site for the p73 transcriptional repressor ZEB1, leading to the abrogation of ZEB1 binding and increased expression of transactivating p73 isoforms (TAp73).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20807817",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In this study, we investigated the expression and subcellular distribution of two N-terminal isoforms, TAp73 and \u0394Np73, in medulloblastoma cells using immunofluorescence microscopy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20803057",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Proteasomal degradation of p73 is mediated by polyubiquitination-dependent and -independent processes both of which appear, thus far, to lack selectivity for the TAp73 and DeltaNp73 isoforms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20615966",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In general, TAp73 isoforms show proapoptotic activities, whereas members of the N-terminally truncated (\u0394N) p73 subfamily that lack the transactivation domain show antiapoptotic functions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20581467",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The p73 gene possesses an extrinsic P1 promoter and an intrinsic P2 promoter, resulting in TAp73 and DeltaNup73 isoforms, respectively.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20528922",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20194434",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Moreover, we also found that subcellular location of p73 isoforms changes with the culture density increases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19885566",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Moreover, ectopic expression of DeltaNp73alpha (but not other p73 isoforms) increased alphaB-crystallin mRNA levels in the absence of p53.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777343",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Like wt p53, TAp63 and TAp73 isoforms transactivate target genes that activate apoptosis signaling pathways.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19615968",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The TP73 gene gives rise to transactivation domain-p73 isoforms (TAp73) as well as DeltaNp73 variants with a truncated N terminus.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19509292",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In contrast, antiapoptotic DeltaNp73 isoforms lack the TA domain and are dominant-negative inhibitors of p53 and TAp73.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19363520",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The isoforms TAp63 and TAp73 transactivate p53 target genes and induce apoptosis, whereas the isoforms DeltaNp63 and DeltaNp73 lack transactivation and might have dominant-negative effects in p53 family members.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19103865",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry. TAp73, DeltaNp73 and DeltaN'p73 were significantly upregulated in tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16964385",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Consequently, different p73 isoforms can be degraded by calpains, i.e., both N-terminal isoforms (TAp73 and DeltaNp73) as well as the C-terminal isoforms (alpha, beta, gamma, delta).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15975558",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Variants lacking the TA domain (DeltaN isoforms) are induced by TAp73 and by p53, and inhibit their transcriptional activity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15781249",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Indeed, tazarotene modulates the expression of the p73 gene in immortalized keratinocyte cell lines by inducing the pro-apoptotic and anti-proliferative TAp73 isoforms and by repressing the anti-apoptotic and pro-proliferative DeltaNp73 isoforms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15610529",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "p73, the first p53 gene homologue, encodes an array of p73 proteins including p73 alpha full-length (TAp73 alpha) and amino-truncated isoforms (Delta Np73 alpha), two proteins with opposite biological functions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14676279",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We further showed that DeltaNp73 is a potent transdominant inhibitor of wild-type p53 and TAp73 in cultured human tumor cells by efficiently counteracting their target gene transactivations, apoptosis, and growth suppression functions (A.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12897129",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In developing sympathetic neurons of mice, p73 is predominantly expressed as a truncated anti-apoptotic isoform (DeltaNp73), which antagonizes both p53 and the full-length p73 protein (TAp73).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11859407",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Interestingly, expression of the Delta Np73 is strongly up-regulated by the TA isoforms and by p53, thus creating a feedback loop that tightly regulates the function of TAp73 and more importantly of p53.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11753569",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020033"
  ],
  "exact_answer": "seven, 7"
}